Jason G. Harp focuses his practice in technically complex patent litigation.
Mr. Harp has worked with clients on intellectual property matters in a
wide range of scientific disciplines. To date, he has counseled clients in
patent infringement actions in the pharmaceutical, biochemistry and
molecular biology, polymer and catalyst chemistry, medical device, and
mechanical fields. In addition, Mr. Harp has significant experience
representing pharmaceutical companies in Hatch-Waxman patent
litigation, including developing invalidity and noninfringement defenses,
drafting detailed noninfringement and invalidity contentions, drafting
claim construction and summary judgment briefs, and taking and
defending depositions. He has also worked closely with technical experts
and inventors in drafting reports and preparing for trials.
Mr. Harp's illustrative patent cases include:
- Carestream Health, Inc. v. Caliper Life Sciences, Inc. (medical
imaging equipment)
- Caliper Life Sciences, Inc., et al. v. Carestream Health, Inc. (noninvasive
medical imaging involving transformed cells)
- Sciele, Inc., et al. v. Lupin Ltd., et al. (metformin)
- Shire, plc v. Mylan, Inc., et al. (lanthanum carbonate)
- Abbott Laboratories v. Mylan, Inc., et al. (lopinavir/ritonavir)
- AstraZeneca Pharmaceuticals LP, et al., v. Sandoz Inc.
(quetiapine)
- AstraZeneca AB, et al. v. Lek Pharmaceutical D.D., et al.
(omeprazole)
- Union Carbide Chemical & Plastics Technology Corp. v. Shell Oil
Co. (catalysts for the production of ethylene oxide)
- C.R. Bard v. Medtronic (blood filter devices)